• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • Cisema as Recommended Social Auditor for German SCDDA By IHK Pfalz

Cisema as Recommended Social Auditor for German SCDDA By IHK Pfalz

Tuesday, 16 November 2021 / Published in News

Cisema as Recommended Social Auditor for German SCDDA By IHK Pfalz

On July 22, 2021, the German Supply Chain Due Diligence Act (SCDDA) was published in the German Federal Law Gazette. Effective from January 1, 2023, onwards, the SCDDA will be applicable to German companies of all sectors with 3,000 employees or more, and will further expand to cover companies with 1,000 employees or more by January 1, 2024. According to SCDDA, German companies, and foreign companies with a branch or subsidiary office in Germany, will be responsible to meet human rights and environmental requirements of its global supply chain.

The SCDDA will heavily impact companies involved in business operations, factory production, sourcing, etc., in China whilst activities of direct and indirect suppliers throughout the entire product cycle (from raw materials to the end product) will need to demonstrate compliance with measures on preventing human rights and environmental rights violations.

IHK Pfalz, also known as the Chamber of Commerce and Industry for the Palatinate, provides expert opinions on various issues, such as economic matters, spatial planning, and many other projects to boost economic growth of the Palatinate’s business sector. Since the German Supply Chain Due Diligence Act (SCDDA) was passed by the German Bundestag on June 11, 2021, Cisema is one of the recommended social auditors for German SCDDA by IHK Pfalz to support German companies with supply chain audits in China.

Contact Cisema or read our service page for quality assurance if you would like to learn more.

Tagged under: SCDDA, Social Audit, Supply Chain Audit

What you can read next

CBEC (Cross Border E-Commerce) – Deliveries Classified as Products for Personal Use
NMPA Specifications for the Quality Management of Cosmetics Production
NMPA Approves Supplementary Testing Methods for Medical Dressing Patches

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP